(Q39967669)

16 September 2017

title

Interferon-alpha inhibits proliferation and induces apoptosis of merkel cell carcinoma in vitro (English)

1 reference

Efstathios N Stathopoulos

16 September 2017

main subject

Merkel cell carcinoma

1 reference

based on heuristic

inferred from title

author

5

object named as

Efstathios N Stathopoulos

1 reference

16 September 2017

author name string

Konstantin Krasagakis

1

1 reference

16 September 2017

Sabine Krüger-Krasagakis

2

1 reference

16 September 2017

George N Tzanakakis

3

1 reference

16 September 2017

Katherine Darivianaki

4

1 reference

16 September 2017

Androniki D Tosca

6

1 reference

16 September 2017

publication date

1 July 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

562-568

1 reference

Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Overview of Merkel cell carcinoma and recent advances in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Merkel-cell carcinoma of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Expression of interleukin 10 in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Chronology of apoptosis in bovine embryos produced in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Expression modes of interferon-α inducible genes in sensitive and resistant human melanoma cells stimulated with regular and pegylated interferon-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Stimulation of primary human endothelial cell proliferation by IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Mechanisms of Interferon-alpha induced apoptosis in malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Improved tolerance of interferon alpha-2a by continuous subcutaneous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701816477

10.1080/07357900701816477

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference